Clinical trial · Interventional
Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer
A Pilot Program to Personalize Care by Integrating Traditional and Complementary Medicine for Women With Ovarian Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to find out if complementary and alternative medicines (CAM) should be included with traditional therapy for women with ovarian cancer. Some of the alternative medicines include non-traditional drug and herbal therapies along with dietary and nutritional strategies. Only a few of these alternative medicines have been tested with women with ovarian cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CAM Therapies | Other | — | UNRESOLVED |
| Educational Presentations | Other | — | UNRESOLVED |
| Post-study Questionnaire | Other | — | UNRESOLVED |
| Pre-study Questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Complementary and Alternative Medicine (CAM) therapies
- description
- This pilot program attends to the need for appropriate patient-centered interventions that integrate CAM with traditional care to maximize both quantity and QOL for women with ovarian cancer.
- interventionNames
- Other: Pre-study Questionnaire
- Other: Educational Presentations
- Other: CAM Therapies
- Other: Post-study Questionnaire
Primary outcomes (1)
- measure
- Number of Participants Interested in Complementary and Alternative Medicines (CAM)
- timeFrame
- Average of 18 Weeks
- description
- Aim 1, proportions of participants who attend the education sessions (with 95% confidence intervals) will be calculated for each of the 5 CAM therapies. Mean (along with SD) score will be calculated for each therapy.
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * A diagnosis of ovarian cancer * An Eastern Cooperative Oncology Group (ECOG) score of 2 or less with a life expectancy of at least 12 months * A patient being treated by a gynecologic oncologist in the Center for Women's Oncology * Ability to read, understand, and sign the informed consent form * Ability to read, write and understand English, which will be the language used in the materials and oral presentations * Willingness to complete pre-test and post-test questionnaires * Willingness to complete brief questionnaires at each session * Willingness to participate in one follow-up telephone interview at 8 weeks after the final session * Willingness to participate in four sessions that take place at Moffitt Cancer Center * Access to transportation, with the ability to travel to and from Moffitt to participate in the sessions
References
Publications (0)
Data not yet available